Literature DB >> 28990310

The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.

Irene Orlow1, Yang Shi2, Peter A Kanetsky3, Nancy E Thomas4, Li Luo5, Sergio Corrales-Guerrero1, Anne E Cust6, Lidia Sacchetto7, Roberto Zanetti7, Stefano Rosso7, Bruce K Armstrong8, Terence Dwyer9, Alison Venn10, Richard P Gallagher11, Stephen B Gruber12, Loraine D Marrett13, Hoda Anton-Culver14, Klaus Busam15, Colin B Begg1, Marianne Berwick5.   

Abstract

Evidence on the relationship between the vitamin D pathway and outcomes in melanoma is growing, although it is not always clear. We investigated the impact of measured levels of sun exposure at diagnosis on associations of vitamin D receptor gene (VDR) polymorphisms and melanoma death in 3336 incident primary melanoma cases. Interactions between six SNPs and a common 3'-end haplotype were significant (p < .05). These SNPs, and a haplotype, had a statistically significant association with survival among subjects exposed to high UVB in multivariable regression models and exerted their effect in the opposite direction among those with low UVB. SNPs rs1544410/BsmI and rs731236/TaqI remained significant after adjustment for multiple testing. These results suggest that the association between VDR and melanoma-specific survival is modified by sun exposure around diagnosis, and require validation in an independent study. Whether the observed effects are dependent or independent of vitamin D activation remains to be determined.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SNP; UVB; exposure; haplotype; interaction; melanoma; polymorphism; survival; vitamin D receptor

Mesh:

Substances:

Year:  2017        PMID: 28990310      PMCID: PMC5809306          DOI: 10.1111/pcmr.12653

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  54 in total

1.  An efficient Monte Carlo approach to assessing statistical significance in genomic studies.

Authors:  D Y Lin
Journal:  Bioinformatics       Date:  2004-09-28       Impact factor: 6.937

2.  Kaplan-Meier methods yielded misleading results in competing risk scenarios.

Authors:  Danielle A Southern; Peter D Faris; Rollin Brant; P Diane Galbraith; Colleen M Norris; Merril L Knudtson; William A Ghali
Journal:  J Clin Epidemiol       Date:  2006-10       Impact factor: 6.437

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.

Authors:  Philippe Saiag; Philippe Aegerter; Dominique Vitoux; Celeste Lebbé; Pierre Wolkenstein; Nicolas Dupin; Vincent Descamps; Selim Aractingi; Elisa Funck-Brentano; Philippe Autier; Miruna Dragomir; Mathieu Boniol
Journal:  J Natl Cancer Inst       Date:  2015-09-15       Impact factor: 13.506

5.  Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.

Authors:  J A Eisman; D H Barkla; P J Tutton
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

6.  Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis.

Authors:  Nancy E Thomas; Anne Kricker; Lynn From; Klaus Busam; Robert C Millikan; Mary E Ritchey; Bruce K Armstrong; Julia Lee-Taylor; Loraine D Marrett; Hoda Anton-Culver; Roberto Zanetti; Stefano Rosso; Richard P Gallagher; Terence Dwyer; Chris Goumas; Peter A Kanetsky; Colin B Begg; Irene Orlow; Homer Wilcox; Susan Paine; Marianne Berwick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-27       Impact factor: 4.254

7.  Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma.

Authors:  T Gambichler; M Bindsteiner; S Höxtermann; A Kreuter
Journal:  Br J Dermatol       Date:  2012-10-05       Impact factor: 9.302

8.  Sun exposure prior to diagnosis is associated with improved survival in melanoma patients: results from a long-term follow-up study of Italian patients.

Authors:  Stefano Rosso; Francesco Sera; Nereo Segnan; Roberto Zanetti
Journal:  Eur J Cancer       Date:  2008-04-10       Impact factor: 9.162

9.  25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.

Authors:  Julia A Newton-Bishop; John R Davies; Faheem Latheef; Juliette Randerson-Moor; May Chan; Jo Gascoyne; Saila Waseem; Susan Haynes; Charles O'Donovan; D Timothy Bishop
Journal:  Int J Cancer       Date:  2014-12-13       Impact factor: 7.396

10.  Low serum 25-hydroxyvitamin d concentrations are associated with increased risk for melanoma and unfavourable prognosis.

Authors:  Benjamin Bade; Alexander Zdebik; Stefan Wagenpfeil; Stefan Gräber; Jürgen Geisel; Thomas Vogt; Jörg Reichrath
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

View more
  2 in total

Review 1.  Current Molecular Markers of Melanoma and Treatment Targets.

Authors:  Kevin Yang; Allen S W Oak; Radomir M Slominski; Anna A Brożyna; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

2.  Personalized electro-acupuncture versus auricular-acupuncture comparative effectiveness (PEACE): A protocol of a randomized controlled trial for chronic musculoskeletal pain in cancer survivors.

Authors:  Kevin T Liou; Ray Baser; Sally A D Romero; Jamie Green; Q Susan Li; Irene Orlow; Katherine S Panageas; Jun J Mao
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.